Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report

Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：180
  • REPORT CODE：GMM858561
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market report explains the definition, types, applications, major countries, and major players of the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Tesaro

    • Mundipharma

    • Roche

    • Heron Therapeutics

    • Qilu Pharma

    • Eisai

    • Teva

    • Merck

    • Mylan

    • Novartis

    By Type:

    • 5-HT3 Inhibitors

    • NK1 Inhibitors

    • Other

    By End-User:

    • Highly Emetogenic Chemotherapy

    • Moderately Emetogenic Chemotherapy

    • Low Emetogenic Chemotherapy

    • Other

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Outlook to 2028- Original Forecasts

    • 2.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market- Recent Developments

    • 6.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market News and Developments

    • 6.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Deals Landscape

    7 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Materials and Cost Structure Analysis

    • 7.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials

    • 7.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price Trend of Key Raw Materials

    • 7.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Suppliers of Raw Materials

    • 7.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Rate of Raw Materials

    • 7.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Cost Structure Analysis

      • 7.5.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Raw Materials Analysis

      • 7.5.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Labor Cost Analysis

      • 7.5.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturing Expenses Analysis

    8 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Export by Region (Top 10 Countries) (2017-2028)

    9 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global 5-HT3 Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global NK1 Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Highly Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Moderately Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Low Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Other Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Outlook till 2022

    • 10.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.2.2 Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.2.3 Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.2 UK Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.3 Spain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.4 Belgium Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.5 France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.6 Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.7 Denmark Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.8 Finland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.9 Norway Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.10 Sweden Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.11 Poland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.12 Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.3.13 Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.2 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.4 South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.5 Pakistan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.6 Bangladesh Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.7 Indonesia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.8 Thailand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.9 Singapore Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.10 Malaysia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.11 Philippines Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.4.12 Vietnam Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.2 Colombia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.3 Chile Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.4 Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.5 Venezuela Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.6 Peru Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.7 Puerto Rico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.5.8 Ecuador Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.2 Kuwait Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.3 Oman Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.4 Qatar Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.7.2 South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.7.3 Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.7.4 Algeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

      • 10.8.2 New Zealand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption (2017-2022)

    11 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Competitive Analysis

    • 11.1 Tesaro

      • 11.1.1 Tesaro Company Details

      • 11.1.2 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.1.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Mundipharma

      • 11.2.1 Mundipharma Company Details

      • 11.2.2 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.2.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Roche

      • 11.3.1 Roche Company Details

      • 11.3.2 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.3.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Heron Therapeutics

      • 11.4.1 Heron Therapeutics Company Details

      • 11.4.2 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.4.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Qilu Pharma

      • 11.5.1 Qilu Pharma Company Details

      • 11.5.2 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.5.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Eisai

      • 11.6.1 Eisai Company Details

      • 11.6.2 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.6.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Teva

      • 11.7.1 Teva Company Details

      • 11.7.2 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.7.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Merck

      • 11.8.1 Merck Company Details

      • 11.8.2 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.8.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Mylan

      • 11.9.1 Mylan Company Details

      • 11.9.2 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Novartis

      • 11.10.1 Novartis Company Details

      • 11.10.2 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

      • 11.10.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    12 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Outlook by Types and Applications to 2028

    • 12.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global 5-HT3 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global NK1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Highly Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Moderately Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Low Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Analysis and Outlook to 2028

    • 13.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.2.2 Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.2 UK Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.3 Spain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.5 France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.6 Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.8 Finland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.9 Norway Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.11 Poland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.12 Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.2 Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.3 Chile Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.6 Peru Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.3 Oman Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs

    • Figure of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Picture

    • Table Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global 5-HT3 Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global NK1 Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Highly Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Moderately Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Low Emetogenic Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Table North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure UK Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Spain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Belgium Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Denmark Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Finland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Norway Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Sweden Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Poland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Thailand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Singapore Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Philippines Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Colombia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Chile Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Peru Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table GCC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Bahrain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Oman Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Qatar Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Nigeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure Algeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Oceania Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption by Country (2017-2022)

    • Figure Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption and Growth Rate (2017-2022)

    • Table Tesaro Company Details

    • Table Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Mundipharma Company Details

    • Table Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Roche Company Details

    • Table Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Heron Therapeutics Company Details

    • Table Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Qilu Pharma Company Details

    • Table Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Eisai Company Details

    • Table Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Teva Company Details

    • Table Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Merck Company Details

    • Table Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Mylan Company Details

    • Table Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Main Business and Markets Served

    • Table Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Portfolio

    • Figure Global 5-HT3 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NK1 Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Highly Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Moderately Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Low Emetogenic Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Table North America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Germany Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast by Country (2022-2028)

    • Figure Australia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US